BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 11479512)

  • 1. Hemodynamic effects of S-nitrosocysteine, an intravenous regional vasodilator.
    Stuesse DC; Giraud GD; Vlessis AA; Starr A; Trunkey DD
    J Thorac Cardiovasc Surg; 2001 Aug; 122(2):371-7. PubMed ID: 11479512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled nitric oxide: effects on hemodynamics, myocardial contractility, and regional blood flow in dogs with mechanically induced pulmonary artery hypertension.
    Girard C; Fargnoli JM; Godin-Ribuot D; Dutheil V; Maitrasse B; Girardet P; Arvieux CC
    J Heart Lung Transplant; 1996 Jul; 15(7):700-8. PubMed ID: 8820786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodilator actions of the endothelium-derived relaxing factor L-S-nitrosocysteine in anaesthetized rats are markedly diminished by peroxynitrite.
    Graves JE; Bates JN; Kooy NW; Lewis SJ
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1137-41. PubMed ID: 16445582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiopulmonary effects of intravenous prostaglandin E1 during experimental one-lung ventilation.
    Bund M; Henzler D; Walz R; Rossaint R; Piepenbrock S
    Thorac Cardiovasc Surg; 2006 Aug; 54(5):341-7. PubMed ID: 16902884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of ouabain on the vasodilator actions of nitric oxide and S-nitrosothiols in vivo: relevance to the identity of EDRF/EDHF.
    Lewis SJ; Travis MD; Hashmi-Hill MP; Sandock K; Robertson TP; Bates JN
    Vascul Pharmacol; 2006 Dec; 45(6):383-94. PubMed ID: 16861050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-nitrosocysteine elicits hemodynamic responses similar to those of the Bezold-Jarisch reflex via activation of stereoselective recognition sites.
    Lewis SJ; Owen JR; Bates JN
    Eur J Pharmacol; 2006 Feb; 531(1-3):254-8. PubMed ID: 16438953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary vascular and hemodynamic effects of prostaglandin E1 in unanesthetized sheep.
    Ogletree ML; Brigham KL
    Microcirc Endothelium Lymphatics; 1984 Jun; 1(3):307-27. PubMed ID: 6546148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of voltage-sensitive Ca(2+)-channels markedly diminishes nitric oxide- but not L-S-nitrosocysteine- or endothelium-dependent vasodilation in vivo.
    Travis MD; Hoque A; Bates JN; Lewis SJ
    Eur J Pharmacol; 2000 Nov; 408(3):289-98. PubMed ID: 11090646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional hemodynamic effects of purinergic P2 receptor subtype agonists in rats.
    Cox BF; Smits GJ
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1492-500. PubMed ID: 8667215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs.
    Leather HA; Ver Eycken K; Segers P; Herijgers P; Vandermeersch E; Wouters PF
    Crit Care Med; 2003 Sep; 31(9):2339-43. PubMed ID: 14501965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
    Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
    Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The developmental effects of prostaglandin D2 on the pulmonary and systemic circulations in the newborn lamb.
    Soifer SJ; Morin FC; Kaslow DC; Heymann MA
    J Dev Physiol; 1983 Aug; 5(4):237-50. PubMed ID: 6579103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of prostacyclin on hemodynamic and coronary blood flow in dogs.
    Teesalu R; Kòrgevee A
    Biomed Biochim Acta; 1988; 47(10-11):S56-9. PubMed ID: 3073770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N; McAlpine L; Peacock AJ; Madhok R
    Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The circulatory effects of epinephrine infusion in the anesthesized piglet.
    Barrington K; Chan W
    Pediatr Res; 1993 Feb; 33(2):190-4. PubMed ID: 8433894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
    Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of prostaglandin F2alpha on the systemic and regional hemodynamics of dogs].
    Flerov EV; Ismailov ShI
    Farmakol Toksikol; 1977; 40(1):44-50. PubMed ID: 852545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.
    Fitzgerald RK; Oishi P; Ovadia B; Ross GA; Reinhartz O; Johengen MJ; Fineman JR
    Pediatr Crit Care Med; 2004 Nov; 5(6):571-7. PubMed ID: 15530195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.